Publications

Mallampalli RK, Coon TA, Glasser JR, et al. Targeting F box protein Fbxo3 to control cytokine-driven inflammation. Journal of Immunology. 2013;191:5247-5255.

Chen BB, Glasser JR, Coon TA, Mallampalli RK. Skp-cullin-F box E3 ligase component FBXL2 ubiquitinates Aurora B to inhibit tumorigenesis. Cell Death and Disease. 2013;4.

Bednash JS, Mallampalli RK. Regulation of inflammasomes by ubiquitination. Cellular and Molecular Immunology. 2016;13:722-728.

Weathington NM, Mallampalli RM. New insights on the function of SCF ubiquitin E3 ligases in the lung. Cell Signaling. 2013;25(9):1792-1798.

Han S, Lear TB, Jerome JA, et al. Lipopolysaccharide primes the NALP3 inflammasome by inhibiting its ubiquitination and degradtion mediated by the SCFFBXL2 E3 ligase. Journal of Biological Chemistry. 2015;290(29):18124-18133.

Chen BB, Glasser JR, Coon TA, et al. F-box protein FBXL2 targets cyclin D2 for ubiquitination and degradation to inhibit leukemic cell proliferation. Blood. 2012;119(13):3132-3141.

Chen B, Glasser J, Coon T, Mallampalli R. F-box protein FBXL2 exerts human lung tumor suppressor-like activity by ubiquitin-mediated degradation of cyclin D3 resluting in cell cycle arrest. Oncogene. 2012;31:2566-2579.

Krzysiak TC, Chen BB, Lear T, Mallampalli R, Groneborn AM. Crystal structure and interaction studies of the human FBxo3 ApaG domain. FEBS Journal. 2016;283(11):2091-2101.

Chen B, Coon TA, Glasser JR, et al. A combinatorial F box protein directed pathway controls TRAF adaptor stability to regulate inflammation. Nature Immunology. 2013;14(5):470 - 479.

Chen BB, Coon TA, Glasser JR, Mallampalli RK. Calmodulin antagonizes a calcium-activated SCF Ubiquitin E3 ligase subunit, FBXL2, to regulate surfactant homeostasis. Molecular and Cellular Biology. 2011;31(9):1905-1920.